What is Pharmacopeial Forum?

Vol. 35, No. 6,  (549KB)
(November-December 2009)

Errata  (38KB)

Pharmacopeial Standards for the Subdivision Characteristics of Scored Tablets  (134KB)

A Recombinant Factor C Procedure for the Detection of Gram-negative Bacterial Endotoxin  (1.7MB)

Transfer of HPLC Procedures to Suitable Columns of Reduced Dimensions and Particle Sizes  (931KB)

Vol. 35, No. 5,  (629KB)
September–October 2009

Interim Revision Announcements  (103KB) Pertaining to USP 32–NF 27 (Official October 1, 2009)

• Budesonide
• Heparin Sodium
• Heparin Sodium Injection
• Nefazodone Hydrochloride
• <1151> Pharmaceutical Dosage Forms  (568KB)

Errata  (41KB)

General Chapter Management in the 2010–2015 Cycle  (200KB)

Transfer of Analytical Procedures: A Proposal for a New General Information Chapter  (56KB)

Visible Particulates in Injections—A History and a Proposal to Revise USP General Chapter Injections <1>  (82KB)

Vol. 35, No. 4,  (327KB)
July–August 2009

Interim Revision Announcements  (85KB) Pertaining to USP 32–NF 27 (Official August 1, 2009)

• Hawthorn Leaf with Flower
• Powdered Hawthorn Leaf with Flower

Errata  (61KB)

Co-processed Excipients  (62KB)

Liquid-filled Gelatin Capsules  (2.7MB)

Vol. 35, No. 3,  (867KB)
May-June 2009

Interim Revision Announcements  (77KB) Pertaining to USP32–NF 27 (Official June 1, 2009)

• Amantadine Hydrochloride Capsules
• Bupropion Hydrochloride Extended–Release Tablets

Errata  (44KB)

Drug Product Performance and Interchangeability of Multisource Drug Substances and Drug Products  (2.4MB)

Topical and Transdermal Drug Products  (2.4MB)

Performance–based Monographs  (2.4MB)

Acceptable, Equivalent, or Better: Approaches for Alternatives to Official Compendial Procedures  (2.4MB)

Vol. 35, No. 2,  (506KB)
March - April 2009

• Galantamine Tablets  (104KB)
• USP Redesigns Pharmacopeial Forum
• USP Implements Guideline on Use of Accelerated Revision Processes
• USP Issues Call for Candidates for 2010-2015 Council of Experts, Its Expert Committees, and Its Advisory Panels

Errata  (63KB)

A Discussion of Net Water Gain for Water Vapor Transmission Rate Determinations  (535KB)

Vol. 35, No. 1,  (750KB)
January–February 2009

Interim Revision Announcements Pertaining to USP 31–NF 26(official February 1, 2009)

• <1052> Biotechnology-Derived Articles – Amino Acids Analysis
• <1053> Biotechnology-Derived Articles – Capillary Electrophoresis
• <1054> Biotechnology-Derived Articles – Isoelectric Focusing
• <1055> Biotechnology-Derived Articles – Peptide Mapping
• <1056> Biotechnology-Derived Articles – Polyacrylamide Gel Electrophoresis

• Amantadine Hydrochloride Capsules
• Bupropion Hydrochloride Extended-Release Tablets

There are no stimuli articles at this time.

• Interim Revision Announcements (Official Dec. 1, 2008)
• Estradiol and Norethindrone Acetate Tablets
• Norgestimate and Ethinyl Estradiol Tablets
• <1066> Physical Environments That Promote Safe Medication Use  (248KB)
• Stimuli Articles

USP Responses to Comments on Stimuli Article: The Application of Uncertainty to USP's Compendial Reference Standards Program: Certified Reference Materials  (527KB)

The Use of Inductively Coupled Plasma–Optical Emission Spectroscopy in the Determination of Heavy Metals in Crospovidone and Povidone as a Replacement for the Concomitant Visual Comparison Test  (527KB)

Compendial Calculations: Recommendations for Improving USP–NF Calculations  (527KB)

General Chapter Containers–Packaging Auxiliary Components <670>  (527KB)

Description of the Upcoming Change in Data Analysis for USP Dissolution Performance Verification Tests  (527KB)

USP Responses to Comments on Stimuli Article Uncertainty Statements Regarding USP Reference Standards  (527KB)

Redesign of the United States Pharmacopeia and National Formulary  (527KB)

General Chapter on Inorganic Impurities: Heavy Metals  (336KB)

The Cadaver Skin Absorption Model and the Drug Development Process  (331KB)

The Inhalation Ad Hoc Advisory Panel for the USP Performance Tests of Inhalation Dosage Forms  (625KB)

Use of Scanning Electron Microscopy in the Authentication of Botanicals  (152KB)

Making Sense of Trueness, Precision, Accuracy, and Uncertainty  (844KB)

Product Performance Test for Medicated Chewing Gums  (1.6MB)

Proposed Change to Acceptance Criteria for Dissolution Performance Verification Testing  (78KB)

Uncertainty Statements Regarding USP Reference Standards  (655KB)

Revision of USP General Chapter Elastomeric Closures for Injection <381>  (215KB)

Proposed New USP General Information Chapter, Excipient Performance <1059>  (146KB)

The Application of Uncertainty to USP's Compendial Reference Standards Program: Certified Reference Materials  (1.6MB)

Toward a Uniform System for Naming Vaccines and Polyclonal Immune Globulins  (123KB)

Assessing Antioxidant Activity in Botanicals and Other Dietary Supplements  (795KB)

Proposed Change to Acceptance Criteria for Dissolution Performance Verification Testing  (1MB)

Summary of Planned Revisions to Design and Analysis of Biological Assays <111>  (70KB)

A New Validated Differential Scanning Calorimetric Procedure for Monitoring the Less Active R,S Isomer of Ethambutol Dihydrochloride in Bulk Drug Samples and Anti-tuberculosis Formulations  (310KB)